Politics By Rachel Cohrs Hospital, physician lobbies sue Biden administration over surprise billing regulation
Politics By Nicholas Florko As Biden touts his effort to cap insulin prices, advocates push for an even more ambitious reform
Politics By Nicholas Florko Califf, nominee to lead FDA, asks Woodcock to stay in leadership role if he’s confirmed
Politics By Nicholas Florko Biden’s new Covid plan: more boosters, free home testing, and ‘monoclonal antibody strike teams’
Politics By Nicholas Florko Califf, Biden’s pick to lead FDA, has millions invested in pharma and tech companies
Politics By Lev Facher Former DARPA director: Biden’s new science agency should be independent, not an NIH office
Politics By Nicholas Florko Moderate Democrats are still seeking changes to the party’s drug pricing package
Politics By Nicholas Florko Biden taps Califf to head FDA — an agency where he has plenty of unfinished business
Exclusive By Rachel Cohrs How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal
Politics By Lev Facher Rochelle Walensky said she’d ‘fix’ the CDC, but nine months in, she’s faltering
Politics By Lev Facher and Rachel Cohrs Democrats circulate a new drug pricing outline with a big carveout for small biotechs
Politics By Nicholas Florko and Rachel Cohrs Here’s where Democrats’ resurrected drug pricing talks are headed
Politics By Maaisha Osman Can a pro-Covid vaccine, anti-mandate position help a Republican win in a Democratic state?
Politics By Rachel Cohrs Pelosi working to gather support for last-minute, last-ditch drug pricing policy
Politics By Rachel Cohrs Congress has bipartisan support to try to deal with the next pandemic. But those talks are already falling behind